We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$585B
AUM Growth
+$29.3B
Cap. Flow
+$1.02B
Cap. Flow %
0.17%
Top 10 Hldgs %
17.95%
Holding
2,642
New
88
Increased
1,025
Reduced
900
Closed
73

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$2.03B
2
DD icon
DuPont de Nemours
DD
+$1.83B
3
CCI icon
Crown Castle
CCI
+$1.58B
4
MSFT icon
Microsoft
MSFT
+$1.48B
5
TRU icon
TransUnion
TRU
+$781M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.53%
3 Technology 15%
4 Consumer Discretionary 13.37%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLK icon
1376
Westlake Corp
WLK
$10.1B
$7.77M ﹤0.01%
93,547
+77,587
+486% +$5.7M
CHUY
1377
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$7.7M ﹤0.01%
365,636
+347,390
+1,904% +$7.37M
BVN icon
1378
Compañía de Minas Buenaventura
BVN
$8.79B
$7.65M ﹤0.01%
598,076
+160,076
+37% +$2.02M
HAIN icon
1379
Hain Celestial
HAIN
$52.9M
$7.62M ﹤0.01%
185,101
-12,193
-6% -$504K
G icon
1380
Genpact
G
$5.7B
$7.57M ﹤0.01%
263,304
-1,810
-0.7% -$51.5K
TWNK
1381
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$7.52M ﹤0.01%
+550,225
New +$7.93M
GLOB icon
1382
Globant
GLOB
$1.77B
$7.47M ﹤0.01%
+186,560
New +$7.69M
EXTN
1383
DELISTED
Exterran Corporation
EXTN
$7.47M ﹤0.01%
236,272
+123,702
+110% +$3.42M
STLD icon
1384
Steel Dynamics
STLD
$37.7B
$7.44M ﹤0.01%
215,773
-7,987
-4% -$280K
PII icon
1385
Polaris
PII
$3.9B
$7.28M ﹤0.01%
69,605
-14,245
-17% -$1.35M
TEO icon
1386
Telecom Argentina
TEO
$5.81B
$7.17M ﹤0.01%
+232,595
New +$6.83M
IMGN
1387
DELISTED
Immunogen Inc
IMGN
$7.15M ﹤0.01%
935,136
+907,500
+3,284% +$6.03M
MRUS
1388
DELISTED
Merus
MRUS
$7.14M ﹤0.01%
359,386
-26,300
-7% -$420K
OGE icon
1389
OGE Energy
OGE
$9.69B
$7.12M ﹤0.01%
197,583
+340
+0.2% +$12.1K
STAY
1390
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$7.12M ﹤0.01%
355,865
+19,980
+6% +$388K
RIGL icon
1391
Rigel Pharmaceuticals
RIGL
$782M
$7.06M ﹤0.01%
278,115
+42,055
+18% +$1.02M
CRZO
1392
DELISTED
Carrizo Oil & Gas Inc
CRZO
$7M ﹤0.01%
408,415
+23,930
+6% +$350K
ERIE icon
1393
Erie Indemnity
ERIE
$13.5B
$6.87M ﹤0.01%
56,963
+2
+0% +$244
MCRB icon
1394
Seres Therapeutics
MCRB
$47.4M
$6.86M ﹤0.01%
21,386
-1,835
-8% -$502K
DISCK
1395
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$6.86M ﹤0.01%
338,570
-75,050
-18% -$1.69M
SASR
1396
DELISTED
Sandy Spring Bancorp Inc
SASR
$6.83M ﹤0.01%
164,796
-1,500
-0.9% -$59K
CRAY
1397
DELISTED
Cray, Inc.
CRAY
$6.7M ﹤0.01%
344,687
-16,236
-4% -$307K
AMRN
1398
Amarin Corp
AMRN
$297M
$6.63M ﹤0.01%
+94,685
New +$6.71M
BHP icon
1399
BHP
BHP
$222B
$6.59M ﹤0.01%
182,275
+13,901
+8% +$508K
PRGS icon
1400
Progress Software
PRGS
$1.79B
$6.56M ﹤0.01%
171,877
-1,585,900
-90% -$53M

Similar funds

T. Rowe Price Associates's Q3 2017 Portfolio in Review

As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
  • T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
  • T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
  • T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.